The niche market of wound care is occupied by a group of around 50 speciality biopharmaceutical companies with proprietary technologies focusing on a number of therapeutic areas. Wound care is a tremendously diverse market - from plasters and bandages to autologous skin replacement - so that within individual approaches there are relatively few competitors. In 40% of cases current standard therapies are ineffective in wound healing, and therefore this article highlights some of the emerging therapies and products being developed to address this unmet clinical need.